Analysis of full-length hepatitis B virus genome from chronic hepatitis B-patients with higher alanine aminotransferase elevation

被引:0
作者
Takahashi, Hiroshi [1 ]
Kanda, Tatsuo [1 ]
Matsumoto, Naoki [1 ]
Shibata, Toshikatsu [1 ]
Nirei, Kazushige [1 ]
Tamura, Akinori [1 ]
Matsuoka, Shunichi [1 ]
Kuroda, Kazumichi [1 ]
Moriyama, Mitsuhiko [1 ]
机构
[1] Nihon Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol,Itabashi Ku, 30-1 Oyaguchi Kamicho, Tokyo 1738610, Japan
关键词
acute exacerbation; ALT; full-length HBV sequence; HBV; HCC; reactivation; virologic breakthrough; C CHRONIC HEPATITIS; CORE PROMOTER; RESISTANT MUTATIONS; LAMIVUDINE-RESISTANCE; FULMINANT-HEPATITIS; GENOTYPE; MANAGEMENT; SEQUENCE; MUTANTS; EMERGENCE;
D O I
10.2217/fvl-2020-0104
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background & aim: Higher elevation of alanine aminotransferase (ALT) occasionally leads to severe outcomes in hepatitis B virus (HBV)-infected patients. Our aim is to investigate the HBV sequence mutations associated with higher ALT elevation. Materials & methods: We analyzed full-length HBV sequences from patients with or without higher ALT elevation. Results: Nucleotide mutations in precore and core regions, which are associated with severe hepatitis B, were found in two HBV-infected patients with higher ALT elevation. Amino acid mutations within the pre-S1, pre-S2 and S regions were also found in a patient with HBV virologic breakthrough during the use of nucleoside analogs. Conclusion: It may be useful for HBV-infected patients with higher ALT elevation to analyze full-length HBV genome.
引用
收藏
页码:429 / 439
页数:11
相关论文
共 39 条
  • [1] Evaluation of anti-HBV drug resistant mutations among patients with acute symptomatic hepatitis B in the United States
    Baxa, Dwayne M.
    Thekdi, Ashish D.
    Golembieski, Alicia
    Krishnan, Prashant V.
    Sharif, Omar
    Kizy, Anne
    Shetron-Rama, Lynne
    Jovanovich, John
    Chappell, Brandi J.
    Snow-Lampart, Andrea
    Borroto-Esoda, Katyna
    Gordon, Stuart C.
    [J]. JOURNAL OF HEPATOLOGY, 2013, 58 (02) : 212 - 216
  • [2] Do the circulating Pre-S/S quasispecies influence the hepatitis B virus surface antigen levels in the HBeAg negative phase of HBV infection?
    Cavallone, Daniela
    Ricco, Gabriele
    Oliveri, Filippo
    Colombatto, Piero
    Moriconi, Francesco
    Coco, Barbara
    Romagnoli, Veronica
    Salvati, Antonio
    Surace, Lidia
    Bonino, Ferruccio
    Brunetto, Maurizia Rossana
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (12) : 1406 - 1416
  • [3] MUTATIONS IN CORE NUCLEOTIDE-SEQUENCE OF HEPATITIS B-VIRUS CORRELATE WITH FULMINANT AND SEVERE HEPATITIS
    EHATA, T
    OMATA, M
    CHUANG, WL
    YOKOSUKA, O
    ITO, Y
    HOSODA, K
    OHTO, M
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (03) : 1206 - 1213
  • [4] Nucleotide analogue-resistant mutations in hepatitis B viral genomes found in hepatitis B patients
    Fan, Jiyun
    Zhang, Yaqing
    Xiong, Hui
    Wang, Ying
    Guo, Xiaokui
    [J]. JOURNAL OF GENERAL VIROLOGY, 2015, 96 : 663 - 670
  • [5] Hepatitis B virus reactivation in patients with rheumatoid arthritis: Analysis of the National Database of Japan
    Fujita, M.
    Sugiyama, M.
    Sato, Y.
    Nagashima, K.
    Takahashi, S.
    Mizokami, M.
    Hata, A.
    [J]. JOURNAL OF VIRAL HEPATITIS, 2018, 25 (11) : 1312 - 1320
  • [6] The two different states of hepatitis B virus DNA in asymptomatic carriers - HBe-antigen-positive versus anti-HBe-positive asymptomatic carriers
    Fujiwara, K
    Yokosuka, O
    Ehata, T
    Chuang, WL
    Imazeki, F
    Saisho, H
    Omata, M
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1998, 43 (02) : 368 - 376
  • [7] GUNTHER S, 1995, J VIROL, V69, P5437
  • [8] A proposal for management of rheumatic disease patients with hepatitis B virus infection receiving immunosuppressive therapy
    Harigai, Masayoshi
    Mochida, Satoshi
    Mimura, Toshihide
    Koike, Takao
    Miyasaka, Nobuyuki
    [J]. MODERN RHEUMATOLOGY, 2014, 24 (01) : 1 - 7
  • [9] Prevalence and clinical characterization of patients with acute hepatitis B induced by lamivudine-resistant strains
    Hayashi, Kazuhiko
    Katano, Yoshiaki
    Ishigami, Masatoshi
    Itoh, Akihiro
    Hirooka, Yoshiki
    Nakano, Isao
    Yoshioka, Kentaro
    Yano, Motoyoshi
    Toyoda, Hidenori
    Kumada, Takashi
    Goto, Hidemi
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 (04) : 745 - 749
  • [10] Unfavorable prognosis of patients with acute liver injury due to drug-induced liver injury and acute exacerbation of hepatitis B virus infection
    Kakisaka, Keisuke
    Suzuki, Yuji
    Jinnouchi, Yukina
    Kanazawa, Jo
    Sasaki, Tokio
    Yonezawa, Takehiro
    Yoshida, Yuichi
    Kuroda, Hidekatsu
    Takikawa, Yasuhiro
    [J]. HEPATOLOGY RESEARCH, 2019, 49 (11) : 1286 - 1293